Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 36.36
(-0.98%)
CNY 36.36
(-0.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 172.51 Million CNY | -78.08% |
| 2022 | 1.01 Billion CNY | -9.59% |
| 2021 | 1.12 Billion CNY | 73.7% |
| 2020 | 647.18 Million CNY | 624.53% |
| 2019 | 89.32 Million CNY | 28.83% |
| 2018 | 69.33 Million CNY | 48.38% |
| 2017 | 46.72 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 62.25 Million CNY | 2.39% |
| 2024 Q3 | 56.38 Million CNY | -7.12% |
| 2024 Q1 | 60.8 Million CNY | -33.66% |
| 2023 Q2 | 42.46 Million CNY | -4.54% |
| 2023 FY | 222.77 Million CNY | -78.08% |
| 2023 Q4 | 91.66 Million CNY | 108.78% |
| 2023 Q3 | 43.9 Million CNY | 3.38% |
| 2023 Q1 | 44.48 Million CNY | 354.05% |
| 2022 Q3 | 128.93 Million CNY | -55.02% |
| 2022 Q1 | 618.26 Million CNY | 269.05% |
| 2022 Q2 | 286.67 Million CNY | -53.63% |
| 2022 FY | 1.01 Billion CNY | -9.59% |
| 2022 Q4 | -17.51 Million CNY | -113.58% |
| 2021 FY | 1.12 Billion CNY | 73.7% |
| 2021 Q4 | 167.52 Million CNY | -21.06% |
| 2021 Q3 | 212.21 Million CNY | -15.97% |
| 2021 Q2 | 252.55 Million CNY | -17.05% |
| 2021 Q1 | 304.45 Million CNY | 119.4% |
| 2020 FY | 647.18 Million CNY | 624.53% |
| 2020 Q4 | 138.76 Million CNY | 33.06% |
| 2020 Q3 | 104.29 Million CNY | -67.96% |
| 2020 Q2 | 325.52 Million CNY | 890.84% |
| 2020 Q1 | 32.85 Million CNY | 0.0% |
| 2019 FY | 89.32 Million CNY | 28.83% |
| 2018 FY | 69.33 Million CNY | 48.38% |
| 2017 FY | 46.72 Million CNY | 0.0% |